Quince Therapeutics, Inc. Common Stock (QNCX) is a publicly traded Healthcare sector company. As of July 29, 2026, QNCX trades at $17.88 with a market cap of $17.46M and a P/E ratio of -10.57. QNCX moved +0.00% today. Year to date, QNCX is -97.34%; over the trailing twelve months it is -95.18%. Its 52-week range spans $15.10 to $909.98. Analyst consensus is strong buy with an average price target of $86.67. Rallies surfaces QNCX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Quince Therapeutics, Inc. Common Stock (QNCX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. QNCX moved +0.00% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $17.88 |
| Market Cap | $17.46M |
| P/E Ratio | -10.57 |
| EPS | $-1.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $909.98 |
| 52-Week Low | $15.10 |
| Volume | 17.38K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-80.77M |
| Gross Margin | 0.00% |
3 analysts cover QNCX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $86.67.